{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:24:50Z","timestamp":1790166290264,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T00:00:00Z","timestamp":1313366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1743-422x-8-402","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T06:42:28Z","timestamp":1313476948000},"source":"Crossref","is-referenced-by-count":29,"title":["Selection of hepatitis C virus resistant to ribavirin"],"prefix":"10.1186","volume":"8","author":[{"given":"Dino A","family":"Feigelstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen B","family":"Mihalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Feinstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,15]]},"reference":[{"key":"1493_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.22070","volume":"47","author":"RT Chung","year":"2008","unstructured":"Chung RT, Gale M Jr, Polyak SJ, Lemon SM, Liang TJ, Hoofnagle JH: Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop. Hepatology 2008, 47: 306-320.","journal-title":"Hepatology"},{"key":"1493_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.gastro.2010.03.037","volume":"139","author":"JJ Feld","year":"2010","unstructured":"Feld JJ, Lutchman GA, Heller T, Hara K, Pfeiffer JK, Leff RD, Meek C, Rivera M, Ko M, Koh C, et al.: Ribavirin improves early responses to peginterferon through improved interferon signaling. Gastroenterology 2010, 139: 154-162. 10.1053\/j.gastro.2010.03.037","journal-title":"Gastroenterology"},{"key":"1493_CR3","volume-title":"The 61th annual meeting of the American Association for the Study of Liver Diseases, October 29-November 2, Boston, USA","author":"S Zeuzem","year":"2010","unstructured":"Zeuzem S, Asselah T, Angus PW, Zarski JP, Larrey D, Mullhaupt B, Gane EJ, Schuchmann M, Lohse AW, Pol S, et al.: Strong antiviral activity and safety of IFN - sparing treatment with the protease inhibitor BI 201335, the HCV polymerase inhibitor BI 207127 and ribavirin in patients with chronic hepatitis C. The 61th annual meeting of the American Association for the Study of Liver Diseases, October 29-November 2, Boston, USA 2010."},{"key":"1493_CR4","volume-title":"The 61th annual meeting of the American Association for the Study of Liver Diseases, October 29-November 2, Boston, USA","author":"S Zeuzem","year":"2010","unstructured":"Zeuzem S, Buggisch P, Agrawal K, Manns MP, Marcellin P, Foster GR, Sereni D, Klinker H, Moreno C, Zarski JP, et al.: Dual, Triple, and Quadruple Combination Treatment with a Protease Inhibitor (GS -9256) and a Polymerase Inhibitor (GS - 9190) alone and in Combination with Ribavirin (RBV) or PegIFN\/RBV for up to 28 days in Treatment Naive, Genotype 1 HCV Subjects. The 61th annual meeting of the American Association for the Study of Liver Diseases, October 29-November 2, Boston, USA 2010."},{"key":"1493_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.antiviral.2009.12.008","volume":"85","author":"SS Hmwe","year":"2010","unstructured":"Hmwe SS, Aizaki H, Date T, Murakami K, Ishii K, Miyamura T, Koike K, Wakita T, Suzuki T: Identification of hepatitis C virus genotype 2a replicon variants with reduced susceptibility to ribavirin. Antiviral Res 2010, 85: 520-524. 10.1016\/j.antiviral.2009.12.008","journal-title":"Antiviral Res"},{"key":"1493_CR6","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1128\/JVI.79.4.2346-2355.2005","volume":"79","author":"JK Pfeiffer","year":"2005","unstructured":"Pfeiffer JK, Kirkegaard K: Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA. J Virol 2005, 79: 2346-2355. 10.1128\/JVI.79.4.2346-2355.2005","journal-title":"J Virol"},{"key":"1493_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/hep.1840380413","volume":"38","author":"KC Young","year":"2003","unstructured":"Young KC, Lindsay KL, Lee KJ, Liu WC, He JW, Milstein SL, Lai MM: Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology 2003, 38: 869-878.","journal-title":"Hepatology"},{"key":"1493_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"BD Lindenbach","year":"2005","unstructured":"Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, et al.: Complete replication of hepatitis C virus in cell culture. Science 2005, 309: 623-626. 10.1126\/science.1114016","journal-title":"Science"},{"key":"1493_CR9","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1128\/JVI.02280-08","volume":"83","author":"KD Ibarra","year":"2009","unstructured":"Ibarra KD, Pfeiffer JK: Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. J Virol 2009, 83: 4538-4547. 10.1128\/JVI.02280-08","journal-title":"J Virol"},{"key":"1493_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1743-422X-7-44","volume":"7","author":"DA Feigelstock","year":"2010","unstructured":"Feigelstock DA, Mihalik KB, Kaplan G, Feinstone SM: Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I. Virol J 2010, 7: 44. 10.1186\/1743-422X-7-44","journal-title":"Virol J"},{"key":"1493_CR11","doi-asserted-by":"publisher","first-page":"46094","DOI":"10.1074\/jbc.C100349200","volume":"276","author":"D Maag","year":"2001","unstructured":"Maag D, Castro C, Hong Z, Cameron CE: Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J Biol Chem 2001, 276: 46094-46098. 10.1074\/jbc.C100349200","journal-title":"J Biol Chem"},{"key":"1493_CR12","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1021\/bi0344681","volume":"42","author":"NV Vo","year":"2003","unstructured":"Vo NV, Young KC, Lai MM: Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase. Biochemistry 2003, 42: 10462-10471. 10.1021\/bi0344681","journal-title":"Biochemistry"},{"key":"1493_CR13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/135965350701200505","volume":"12","author":"E Brochot","year":"2007","unstructured":"Brochot E, Duverlie G, Castelain S, Morel V, Wychowski C, Dubuisson J, Francois C: Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity. Antivir Ther 2007, 12: 805-813.","journal-title":"Antivir Ther"},{"key":"1493_CR14","doi-asserted-by":"publisher","first-page":"8505","DOI":"10.1128\/JVI.76.17.8505-8517.2002","volume":"76","author":"AM Contreras","year":"2002","unstructured":"Contreras AM, Hiasa Y, He W, Terella A, Schmidt EV, Chung RT: Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol 2002, 76: 8505-8517. 10.1128\/JVI.76.17.8505-8517.2002","journal-title":"J Virol"},{"key":"1493_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1053\/j.gastro.2006.12.005","volume":"132","author":"WP Hofmann","year":"2007","unstructured":"Hofmann WP, Polta A, Herrmann E, Mihm U, Kronenberger B, Sonntag T, Lohmann V, Schonberger B, Zeuzem S, Sarrazin C: Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy. Gastroenterology 2007, 132: 921-930. 10.1053\/j.gastro.2006.12.005","journal-title":"Gastroenterology"},{"key":"1493_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2893.2004.00531.x","volume":"11","author":"T Kanda","year":"2004","unstructured":"Kanda T, Yokosuka O, Imazeki F, Tanaka M, Shino Y, Shimada H, Tomonaga T, Nomura F, Nagao K, Ochiai T, et al.: Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA. J Viral Hepat 2004, 11: 479-487. 10.1111\/j.1365-2893.2004.00531.x","journal-title":"J Viral Hepat"},{"key":"1493_CR17","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1053\/j.gastro.2007.03.035","volume":"132","author":"G Lutchman","year":"2007","unstructured":"Lutchman G, Danehower S, Song BC, Liang TJ, Hoofnagle JH, Thomson M, Ghany MG: Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy. Gastroenterology 2007, 132: 1757-1766. 10.1053\/j.gastro.2007.03.035","journal-title":"Gastroenterology"},{"key":"1493_CR18","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.1128\/JVI.00382-07","volume":"81","author":"S Chevaliez","year":"2007","unstructured":"Chevaliez S, Brillet R, Lazaro E, Hezode C, Pawlotsky JM: Analysis of ribavirin mutagenicity in human hepatitis C virus infection. J Virol 2007, 81: 7732-7741. 10.1128\/JVI.00382-07","journal-title":"J Virol"},{"key":"1493_CR19","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1128\/JCM.43.11.5679-5684.2005","volume":"43","author":"T Kato","year":"2005","unstructured":"Kato T, Date T, Miyamoto M, Sugiyama M, Tanaka Y, Orito E, Ohno T, Sugihara K, Hasegawa I, Fujiwara K, et al.: Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J Clin Microbiol 2005, 43: 5679-5684. 10.1128\/JCM.43.11.5679-5684.2005","journal-title":"J Clin Microbiol"},{"key":"1493_CR20","doi-asserted-by":"publisher","first-page":"18202","DOI":"10.1074\/jbc.M413410200","volume":"280","author":"BK Biswal","year":"2005","unstructured":"Biswal BK, Cherney MM, Wang M, Chan L, Yannopoulos CG, Bilimoria D, Nicolas O, Bedard J, James MN: Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. J Biol Chem 2005, 280: 18202-18210.","journal-title":"J Biol Chem"},{"key":"1493_CR21","doi-asserted-by":"publisher","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","volume":"96","author":"S Bressanelli","year":"1999","unstructured":"Bressanelli S, Tomei L, Roussel A, Incitti I, Vitale RL, Mathieu M, De Francesco R, Rey FA: Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci USA 1999, 96: 13034-13039. 10.1073\/pnas.96.23.13034","journal-title":"Proc Natl Acad Sci USA"},{"key":"1493_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/13305","volume":"6","author":"CA Lesburg","year":"1999","unstructured":"Lesburg CA, Cable MB, Ferrari E, Hong Z, Mannarino AF, Weber PC: Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nature Structural Biology 1999, 6: 937-943. 10.1038\/13305","journal-title":"Nature Structural Biology"},{"key":"1493_CR23","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/82191","volume":"6","author":"S Crotty","year":"2000","unstructured":"Crotty S, Maag D, Arnold JJ, Zhong W, Lau JY, Hong Z, Andino R, Cameron CE: The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med 2000, 6: 1375-1379. 10.1038\/82191","journal-title":"Nat Med"},{"key":"1493_CR24","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.1073\/pnas.1232294100","volume":"100","author":"JK Pfeiffer","year":"2003","unstructured":"Pfeiffer JK, Kirkegaard K: A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci USA 2003, 100: 7289-7294. 10.1073\/pnas.1232294100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1493_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature04388","volume":"439","author":"M Vignuzzi","year":"2006","unstructured":"Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R: Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 2006, 439: 344-348. 10.1038\/nature04388","journal-title":"Nature"},{"key":"1493_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.virusres.2004.11.007","volume":"107","author":"M Vignuzzi","year":"2005","unstructured":"Vignuzzi M, Stone JK, Andino R: Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res 2005, 107: 173-181. 10.1016\/j.virusres.2004.11.007","journal-title":"Virus Res"},{"key":"1493_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00007691-200010000-00010","volume":"22","author":"JF Jen","year":"2000","unstructured":"Jen JF, Glue P, Gupta S, Zambas D, Hajian G: Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C. Ther Drug Monit 2000, 22: 555-565. 10.1097\/00007691-200010000-00010","journal-title":"Ther Drug Monit"},{"key":"1493_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/AAC.47.1.124-129.2003","volume":"47","author":"S Larrat","year":"2003","unstructured":"Larrat S, Stanke-Labesque F, Plages A, Zarski JP, Bessard G, Souvignet C: Ribavirin quantification in combination treatment of chronic hepatitis C. Antimicrob Agents Chemother 2003, 47: 124-129. 10.1128\/AAC.47.1.124-129.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"1493_CR29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/135965350801300401","volume":"13","author":"M Maynard","year":"2008","unstructured":"Maynard M, Pradat P, Gagnieu MC, Souvignet C, Trepo C: Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients. Antivir Ther 2008, 13: 607-611.","journal-title":"Antivir Ther"},{"key":"1493_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1542-3565(04)00064-3","volume":"2","author":"M Homma","year":"2004","unstructured":"Homma M, Matsuzaki Y, Inoue Y, Shibata M, Mitamura K, Tanaka N, Kohda Y: Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia. Clin Gastroenterol Hepatol 2004, 2: 337-339. 10.1016\/S1542-3565(04)00064-3","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1493_CR31","first-page":"763","volume":"17","author":"HH Hsu","year":"1993","unstructured":"Hsu HH, Donets M, Greenberg HB, Feinstone SM: Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system. Hepatology 1993, 17: 763-771.","journal-title":"Hepatology"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-8-402\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T19:08:48Z","timestamp":1686251328000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-402","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,15]]},"article-number":"402"}}